Cargando…
Vaccine Ab neutralization against Omicron and SARS-CoV-2 variants using neutralization and specific ELISA assays
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906917/ https://www.ncbi.nlm.nih.gov/pubmed/35278483 http://dx.doi.org/10.1016/j.jinf.2022.02.031 |
| _version_ | 1784665504830455808 |
|---|---|
| author | Ferré, Valentine Marie Lebourgeois, Samuel Chenane, Houssem Redha Menidjel, Reyene Masson, Christelle Collin, Gilles Visseaux, Benoit Descamps, Diane Fidouh, Nadhira Charpentier, Charlotte |
| author_facet | Ferré, Valentine Marie Lebourgeois, Samuel Chenane, Houssem Redha Menidjel, Reyene Masson, Christelle Collin, Gilles Visseaux, Benoit Descamps, Diane Fidouh, Nadhira Charpentier, Charlotte |
| author_sort | Ferré, Valentine Marie |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8906917 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | The British Infection Association. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89069172022-03-10 Vaccine Ab neutralization against Omicron and SARS-CoV-2 variants using neutralization and specific ELISA assays Ferré, Valentine Marie Lebourgeois, Samuel Chenane, Houssem Redha Menidjel, Reyene Masson, Christelle Collin, Gilles Visseaux, Benoit Descamps, Diane Fidouh, Nadhira Charpentier, Charlotte J Infect Letter to the Editor The British Infection Association. Published by Elsevier Ltd. 2022-06 2022-03-10 /pmc/articles/PMC8906917/ /pubmed/35278483 http://dx.doi.org/10.1016/j.jinf.2022.02.031 Text en © 2022 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Ferré, Valentine Marie Lebourgeois, Samuel Chenane, Houssem Redha Menidjel, Reyene Masson, Christelle Collin, Gilles Visseaux, Benoit Descamps, Diane Fidouh, Nadhira Charpentier, Charlotte Vaccine Ab neutralization against Omicron and SARS-CoV-2 variants using neutralization and specific ELISA assays |
| title | Vaccine Ab neutralization against Omicron and SARS-CoV-2 variants using neutralization and specific ELISA assays |
| title_full | Vaccine Ab neutralization against Omicron and SARS-CoV-2 variants using neutralization and specific ELISA assays |
| title_fullStr | Vaccine Ab neutralization against Omicron and SARS-CoV-2 variants using neutralization and specific ELISA assays |
| title_full_unstemmed | Vaccine Ab neutralization against Omicron and SARS-CoV-2 variants using neutralization and specific ELISA assays |
| title_short | Vaccine Ab neutralization against Omicron and SARS-CoV-2 variants using neutralization and specific ELISA assays |
| title_sort | vaccine ab neutralization against omicron and sars-cov-2 variants using neutralization and specific elisa assays |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906917/ https://www.ncbi.nlm.nih.gov/pubmed/35278483 http://dx.doi.org/10.1016/j.jinf.2022.02.031 |
| work_keys_str_mv | AT ferrevalentinemarie vaccineabneutralizationagainstomicronandsarscov2variantsusingneutralizationandspecificelisaassays AT lebourgeoissamuel vaccineabneutralizationagainstomicronandsarscov2variantsusingneutralizationandspecificelisaassays AT chenanehoussemredha vaccineabneutralizationagainstomicronandsarscov2variantsusingneutralizationandspecificelisaassays AT menidjelreyene vaccineabneutralizationagainstomicronandsarscov2variantsusingneutralizationandspecificelisaassays AT massonchristelle vaccineabneutralizationagainstomicronandsarscov2variantsusingneutralizationandspecificelisaassays AT collingilles vaccineabneutralizationagainstomicronandsarscov2variantsusingneutralizationandspecificelisaassays AT visseauxbenoit vaccineabneutralizationagainstomicronandsarscov2variantsusingneutralizationandspecificelisaassays AT descampsdiane vaccineabneutralizationagainstomicronandsarscov2variantsusingneutralizationandspecificelisaassays AT fidouhnadhira vaccineabneutralizationagainstomicronandsarscov2variantsusingneutralizationandspecificelisaassays AT charpentiercharlotte vaccineabneutralizationagainstomicronandsarscov2variantsusingneutralizationandspecificelisaassays |